Governing genetics: reifying choice and progress
- PMID: 15282910
- DOI: 10.1080/1463677032000102611
Governing genetics: reifying choice and progress
Abstract
The governance of genetics involves a wide range of policy networks and covers a considerable array of genetic technoscience. Despite this apparent diversity, the uniformity of some genetic governance requires investigation. Reviewing policy documents on genetic patenting and embryonic stem cell research, I shall argue that policy networks often conceive of the ethical aspects of these practices in similar ways. In particular, I shall argue that individual choice and medico-scientific progress are common rhetorical devices in their frameworks. I shall end by commenting upon the implications of these trends for the future.
Similar articles
-
Patenting and ethics--a dubious connection.J Pat Trademark Off Soc. 2003 Jan;85(1):31-47. J Pat Trademark Off Soc. 2003. PMID: 15212036 No abstract available.
-
Some reflections on an international convention on the banning of human cloning and related patents.J World Intellect Prop. 2003 May;6(3):485-505. doi: 10.1111/j.1747-1796.2003.tb00226.x. J World Intellect Prop. 2003. PMID: 15986547 No abstract available.
-
Regulation as facilitation: negotiating the genetic revolution.Mod Law Rev. 1998 Sep;61(5):621-60. doi: 10.1111/1468-2230.00171. Mod Law Rev. 1998. PMID: 14518446 No abstract available.
-
The attack of the clones: patent law and stem cell research.J Law Med. 2003 May;10(4):488-505. J Law Med. 2003. PMID: 12852321 Review.
-
Embryonic stem cell research: can the law balance ethical, scientific and economic values? (Part II).Rev Derecho Genoma Hum. 2003 Jul-Dec;(19):91-108. Rev Derecho Genoma Hum. 2003. PMID: 15032099 Review. No abstract available.
Cited by
-
Global consumption and the challenge to pharmaceutical governance in the United Kingdom.BMJ. 2005 Jul 2;331(7507):40-2. doi: 10.1136/bmj.331.7507.40. BMJ. 2005. PMID: 15994692 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical